UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043398
Receipt number R000049548
Scientific Title Comparative study of inhibitory effects on postprandial blood glucose levels of patients with type 2 diabetes by wax bran layer removal brown rice
Date of disclosure of the study information 2021/02/20
Last modified on 2023/03/28 17:58:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study of inhibitory effects on postprandial blood glucose levels of patients with type 2 diabetes by wax bran layer removal brown rice

Acronym

Inhibitory effects on blood glucose levels by wax bran layer removal rice

Scientific Title

Comparative study of inhibitory effects on postprandial blood glucose levels of patients with type 2 diabetes by wax bran layer removal brown rice

Scientific Title:Acronym

Inhibitory effects on blood glucose levels by wax bran layer removal rice

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirmation of inhibitory effects on postprandial glucose levels of patients with type 2 diabetes by wax bran layer removal rice

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Area under the curve during 0-120min after rice ingestion analyzed by FGM

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

wax bran layer removal rice

Interventions/Control_2

polished rice

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Inpatients with type 2 diabetes
HbA1c above or equal to 7.5% and less than 10.5%

Key exclusion criteria

severe ketosis or diabetic coma within six weeks
severe hypoglycemia within six weeks
severe renal dysfunction or under dialysis therapy
proliferative retinopathy
severe gastrointestinal dysfunction within two weeks or operation of GI tract
pregnant or breastfeeding
severe infection or severe trauma
glucocorticoid therapy
severe liver dysfunction
malignancy
hypersensitive to rice
difficulty to eat test meal
judged as inappropriate by attending physician

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Nishi

Organization

Wakayama Medical University

Division name

Division of Clinical Nutrition and Metabolism

Zip code

641-8509

Address

811-1 Kimiidera, Wakayama-City, Wakayama prefecture

TEL

073-441-0625

Email

mnishi@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Sae
Middle name
Last name Maenishi

Organization

Wakayama Medical University

Division name

Division of Clinical Nutrition and Metabolism

Zip code

641-8509

Address

811-1 Kimiidera, Wakayama-City, Wakayama prefecture

TEL

073-441-0513

Homepage URL


Email

maenishi@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical university
Division of Clinical Nutrition and Metabolism

Institute

Department

Personal name



Funding Source

Organization

Toyo Rice Co.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Toyo Rice Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Wakayama Medical University

Address

811-1 Kimiidera, Wakayama-City, Wakayama prefecture

Tel

073-447-2300

Email

wa-rinri@wakyama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 05 Month 07 Day

Date of IRB

2019 Year 05 Month 14 Day

Anticipated trial start date

2023 Year 03 Month 31 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 20 Day

Last modified on

2023 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049548


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name